AceCann is a Portuguese pharmaceutical-grade medical cannabis company headquartered near Lisbon, operating an 8,000m² state-of-the-art indoor facility in Vendas Novas.

Founded in 2019, AceCann is Portugal's only fully EU-GMP certified indoor cannabis producer, holding a complete suite of Infarmed licenses - GACP, GMP Part I & II, and GDP -enabling the cultivation, processing, and distribution of premium medical cannabis flower to pharmacies and partners across Europe, the UK, Australia, and beyond.

Our premium indoor operation ensures year-round production consistency, uniform cannabinoid and terpene profiles, and full traceability - meeting the highest pharmaceutical standards that European markets demand.

Beyond our own genetics and branded flower, AceCann offers a flexible platform of services including toll-manufacturing (CMO) for third-party GACP-to-EU-GMP conversion, and solventless extraction using pharmaceutical-grade equipment.

Backed by leading cannabis and institutional investors - including Casa Verde Capital, Blue Dream Capital, Lince Capital, BlueCrow Capital and Banco Português de Fomento - AceCann is scaling with purpose and entering new markets.

Our mission: To improve lives through the development of high-quality and innovative medical cannabis products.

Our vision: To be Europe's most trusted medical cannabis company.

AceCann

Org chart

Teams

Offices